01/16/2026
A Creighton University researcher has helped change the future of newborn care nationwide.
Through decades of translational research, collaboration and advocacy, Amy Brower, MD, research professor and senior scholar in Creighton’s Institute for Population Health and assistant dean of research for the School of Medicine, contributed critical evidence that led to the addition of Duchenne Muscular Dystrophy (DMD) to the federal Recommended Uniform Screening Panel.
This milestone paves the way for universal newborn screening of a rare, life-limiting genetic condition and underscores the power of research to shape national health policy.
Dr. Brower’s work exemplifies Creighton’s mission to translate rigorous science into meaningful, real-world impact—and to advance population health through compassionate, evidence-based care.
Learn more about how Creighton University research is shaping national policy and improving lives from the very beginning. https://www.creighton.edu/news/creighton-researcher-secures-nationwide-newborn-screening-duchenne-muscular-dystrophy
Creighton University researcher Amy Brower, PhD, helped secure nationwide newborn screening for Duchenne Muscular Dystrophy, advancing early diagnosis and care for families across the U.S.